88816766
Mar 2, 2020
May 24, 2022
FRESENIUS KABI DEUTSCHLAND GMBH
Active Trademark
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis
Pharmaceuticals